(Q39175078)

9 September 2017

title

Adenosine kinase is a key determinant for the anti-HCV activity of ribavirin (English)

1 reference

9 September 2017

1 reference

Kyoko Mori

1

1 reference

9 September 2017

Osamu Hiraoka

2

1 reference

9 September 2017

Masanori Ikeda

3

1 reference

9 September 2017

Yasuo Ariumi

4

1 reference

9 September 2017

Akiko Hiramoto

5

1 reference

9 September 2017

Yusuke Wataya

6

1 reference

9 September 2017

Nobuyuki Kato

7

1 reference

9 September 2017

language of work or name

English

0 references

publication date

19 August 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

58

1 reference

9 September 2017

issue

4

1 reference

9 September 2017

page(s)

1236-1244

1 reference

Unravelling hepatitis C virus replication from genome to function

9 September 2017

cites work

1 reference

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

21 January 2018

1 reference

Telaprevir for previously untreated chronic hepatitis C virus infection

21 January 2018

1 reference

Boceprevir for untreated chronic HCV genotype 1 infection

21 January 2018

1 reference

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

21 January 2018

1 reference

Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action

21 January 2018

1 reference

Ribavirin potentiates interferon action by augmenting interferon-stimulated gene induction in hepatitis C virus cell culture models

21 January 2018

1 reference

The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA.

21 January 2018

1 reference

Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system.

21 January 2018

1 reference

Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system

21 January 2018

1 reference

Efficient replication systems for hepatitis C virus using a new human hepatoma cell line

21 January 2018

1 reference

Establishment of a hepatitis C virus subgenomic replicon derived from human hepatocytes infected in vitro

21 January 2018

1 reference

Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element.

21 January 2018

1 reference

Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent

21 January 2018

1 reference

Subcellular localization of adenosine kinase in mammalian cells: The long isoform of AdK is localized in the nucleus

21 January 2018

1 reference

ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C.

21 January 2018

1 reference

Cellular IRES-mediated translation: the war of ITAFs in pathophysiological states.

21 January 2018

1 reference

Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex.

21 January 2018

1 reference

Antitumor mechanisms and metabolism of the novel antitumor nucleoside analogues, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.26421

1 reference

9 September 2017

1 reference